期刊名称：TRANSLATIONAL STROKE RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Translational Stroke Research covers basic, translational, and clinical studies. The Journal emphasizes novel approaches to help both to understand clinical phenomenon through basic science tools, and to translate basic science discoveries into the development of new strategies for the prevention, assessment, treatment, and enhancement of central nervous system repair after stroke and other forms of neurotrauma.
Translational Stroke Research focuses on translational research and is relevant to both basic scientists and physicians, including but not restricted to neuroscientists, vascular biologists, neurologists, neuroimagers, and neurosurgeons.
Abstracted/Indexed in
Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, Academic OneFile, Current Contents/Clinical Medicine, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions
Instructions to Authors
Editorial policy
Translational Stroke Research covers basic, translational and clinical studies, which especially emphasizes on novel approaches to help translate the scientific discoveries from basic stroke research into the development of new strategies for the prevention, assessment, treatment, and enhancement of central nervous system repair after stroke and other forms of neurotrauma. The journal focuses on translational research and is relevant to both basic scientists and physicians, including neuroscientists, neurologists and neurosurgeons.
Translational Stroke Research will consider:
Review Articles, Letters/Comments, Brief Communications, Original Research articles, Protocols, Commentaries, Perspective Papers, and Pilot Clinical Trials
The journal is committed to high standards of presentation. Original reports and reviews can be up to 6,000 words in length. Please contact the Editor to discuss the suitability of topics. Brief Communications should be approximately 1500 words long, with no more than 2 figures/tables and 30 references. Correspondence items should be no more than 1000 words in length, with 1 figure or table.
• Methods and Protocols Papers
All methods and protocols papers must follow the below structure:
I. Summary/Abstract
II. Keywords
III. Introduction
IV. Materials:
V. Methods
VI. Notes
VII. References
For protocol samples and more in-depth instructions, please visit:
Manuscript submission
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Authors should submit their manuscripts online. Electronic submission substantially reduces the editorial processing and reviewing times and shortens overall publication times. Please follow the hyperlink “Submit online” on the right and upload all of your manuscript files following the instructions given on the screen.
Title page
Title Page
The title page should include:
- The name(s) of the author(s)
- A concise and informative title
- The affiliation(s) and address(es) of the author(s)
- The e-mail address, telephone and fax numbers of the corresponding author
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
Keywords
Please provide 4 to 6 keywords which can be used for indexing purposes.
Text
Text Formatting
Manuscripts should be submitted in Word.
- Use a normal, plain font (e.g., 10-point Times Roman) for text.
- Use italics for emphasis.
- Use the automatic page numbering function to number the pages.
- Do not use field functions.
- Use tab stops or other commands for indents, not the space bar.
- Use the table function, not spreadsheets, to make tables.
- Use the equation editor or MathType for equations.
- Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
Manuscripts with mathematical content can also be submitted in LaTeX.
Headings
Please use no more than three levels of displayed headings.
Abbreviations
Abbreviations should be defined at first mention and used consistently thereafter.
Footnotes
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.
Acknowledgments
Acknowledgments of people, grants, funds, etc. should be placed in a separate section before the reference list. The names of funding organizations should be written in full.
Scientific style
- Please always use internationally accepted signs and symbols for units (SI units).
- Nomenclature: Insofar as possible, authors should use systematic names similar to those used by Chemical Abstract Service or IUPAC.
- Genus and species names should be in italics.
- Generic names of drugs and pesticides are preferred; if trade names are used, the generic name should be given at first mention.
- Please use the standard mathematical notation for formulae, symbols, etc.:
Italic for single letters that denote mathematical constants, variables, and unknown quantities
Roman/upright for numerals, operators, and punctuation, and commonly defined functions or abbreviations, e.g., cos, det, e or exp, lim, log, max, min, sin, tan, d (for derivative)
Bold for vectors, tensors, and matrices.
References
Citation
Reference citations in the text should be identified by numbers in square brackets. Some examples:
1. Negotiation research spans many disciplines [3].
2. This result was later contradicted by Becker and Seligman [5].
3. This effect has been widely studied [1-3, 7].
Reference list
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.
The entries in the list should be numbered consecutively.
- Journal article
Smith JJ. The world of science. Am J Sci. 1999;36:234–5.
- Article by DOI
Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. J Mol Med. 2000; doi:10.1007/s001090000086
- Book
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.
- Book chapter
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. pp. 251–306.
- Online document
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see
For authors using EndNote, Springer provides an output style that supports the formatting of in-text citations and reference list.
Tables
- All tables are to be numbered using Arabic numerals.
- Tables should always be cited in text in consecutive numerical order.
- For each table, please supply a table caption (title) explaining the components of the table.
- Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
- Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
Artwork and Illustrations Guidelines
For the best quality final product, it is highly recommended that you submit all of your artwork – photographs, line drawings, etc. – in an electronic format. Your art will then be produced to the highest standards with the greatest accuracy to detail. The published work will directly reflect the quality of the artwork provided.
Electronic Figure Submission
- Supply all figures electronically.
- Indicate what graphics program was used to create the artwork.
- For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MS Office files are also acceptable.
- Vector graphics containing fonts must have the fonts embedded in the files.
- Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
Line Art
- Definition: Black and white graphic with no shading.
- Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
- All lines should be at least 0.1 mm (0.3 pt) wide.
- Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
- Vector graphics containing fonts must have the fonts embedded in the files.
Halftone Art
- Definition: Photographs, drawings, or paintings with fine shading, etc.
- If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
- Halftones should have a minimum resolution of 300 dpi.
Combination Art
- Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
- Combination artwork should have a minimum resolution of 600 dpi.
Color Art
- Color art is free of charge for online publication.
- If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
- If the figures will be printed in black and white, do not refer to color in the captions.
- Color illustrations should be submitted as RGB (8 bits per channel).
Figure Lettering
- To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
- Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
- Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
- Avoid effects such as shading, outline letters, etc.
- Do not include titles or captions within your illustrations.
Figure Numbering
- All figures are to be numbered using Arabic numerals.
- Figures should always be cited in text in consecutive numerical order.
- Figure parts should be denoted by lowercase letters (a, b, c, etc.).
- If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures, "A1, A2, A3, etc." Figures in online appendices (Electronic Supplementary Material) should, however, be numbered separately.
Figure Captions
- Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
- Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
- No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
- Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
- Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
Figure Placement and Size
- When preparing your figures, size figures to fit in the column width.
- For most journals the figures should be 39 mm, 84 mm, 129 mm, or 174 mm wide and not higher than 234 mm.
- For books and book-sized journals, the figures should be 80 mm or 122 mm wide and not higher than 198 mm.
Permissions
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.
Accessibility
In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
- All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
- Patterns are used instead of or in addition to colors for conveying information (color-blind users would then be able to distinguish the visual elements)
- Any figure lettering has a contrast ratio of at least 4.5:1
Electronic Supplementary Material
Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.
Submission
- Supply all supplementary material in standard file formats.
- Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
- To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.
Audio, Video, and Animations
- Always use MPEG-1 (.mpg) format.
Text and Presentations
- Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
- A collection of figures may also be combined in a PDF file.
Spreadsheets
- Spreadsheets should be converted to PDF if no interaction with the data is intended.
- If the readers should be encouraged to make their own calculations, spreadsheets should be submitted as .xls files (MS Excel).
Specialized Formats
- Specialized format such as .pdb (chemical), .wrl (VRML), .nb (Mathematica notebook), and .tex can also be supplied.
Collecting Multiple Files
- It is possible to collect multiple files in a .zip or .gz file.
Numbering
- If supplying any supplementary material, the text must make specific mention of the material as a citation, similar to that of figures and tables.
- Refer to the supplementary files as “Online Resource”, e.g., "... as shown in the animation (Online Resource 3)", “... additional data are given in Online Resource 4”.
- Name the files consecutively, e.g. “ESM_3.mpg”, “ESM_4.pdf”.
Captions
- For each supplementary material, please supply a concise caption describing the content of the file.
Processing of supplementary files
- Electronic supplementary material will be published as received from the author without any conversion, editing, or reformatting.
Accessibility
In order to give people of all abilities and disabilities access to the content of your supplementary files, please make sure that
- The manuscript contains a descriptive caption for each supplementary material
- Video files do not contain anything that flashes more than three times per second (so that users prone to seizures caused by such effects are not put at risk)
Compliance with Ethics Requirements
In order to comply with the Journal’s ethical requirements, the following must be included in a separate section entitled “Compliance with Ethics Requirements” just before the reference list. The editors reserve the right to reject manuscripts that do not comply with the below-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the below-mentioned requirements.
Conflict of Interest:
Authors must indicate whether or not they have a financial relationship with the organization that
sponsored the research. The Conflict of Interest statements must list each author separately by name:
John Smith declares that he has no conclict of interest.
Paula Taylor has received research grants from Drug Company A.
Mike Schultz has received a speaker honorarium from Drug Company B and owns stock in Drug Company C.
For studies with human subjects include the following:
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.
If the research was not conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.
If any identifying information about patients is included in the article, the following sentence must also be included:
Additional informed consent was obtained from all patients for which identifying information is included in this article.
For studies with animals include the following sentence:
All institutional and national guidelines for the care and use of laboratory animals were followed.
Clinical Trials
All controlled clinical trials must be registered in a publicly-available database. Authors must include their trial registration information in the cover letter of their manuscript, and should deposit their results in the NIH registry (www.clinicaltrials.gov) or the International Standard Randomized Controlled Trials database (http://isrctn.org).
Does Springer provide English language support?
Manuscripts that are accepted for publication will be checked by our copyeditors for spelling and formal style. This may not be sufficient if English is not your native language and substantial editing would be required. In that case, you may want to have your manuscript edited by a native speaker prior to submission. A clear and concise language will help editors and reviewers concentrate on the scientific content of your paper and thus smooth the peer review process.
The following editing service provides language editing for scientific articles in all areas Springer publishes in.
Use of an editing service is neither a requirement nor a guarantee of acceptance for publication.
Please contact the editing service directly to make arrangements for editing and payment.
For Authors from China
文章在投稿前进行专业的语言润色将对作者的投稿进程有所帮助。作者可自愿选择使用Springer推荐的编辑服务，使用与否并不作为判断文章是否被录用的依据。提高文章的语言质量将有助于审稿人理解文章的内容，通过对学术内容的判断来决定文章的取舍，而不会因为语言问题导致直接退稿。作者需自行联系Springer推荐的编辑服务公司，协商编辑事宜。
For Authors from Japan
ジャーナルに論文を投稿する前に、ネイティブ・スピーカーによる英文校閲を希望されている方には、Edanz社をご紹介しています。サービス内容、料金および申込方法など、日本語による詳しい説明はエダンズグループジャパン株式会社の下記サイトをご覧ください。
For Authors from Korea
영어 논문 투고에 앞서 원어민에게 영문 교정을 받고자 하시는 분들께 Edanz 회사를 소개해 드립니다. 서비스 내용, 가격 및
신청 방법 등에 대한 자세한 사항은 저희 Edanz Editing Global 웹사이트를 참조해 주시면 감사하겠습니다.
Editorial Board
Editor-in-Chief:
John H. Zhang, Loma Linda University, Loma Linda, USA
Associate Editors
Koji Abe, Okayama University, Okayama, Japan
Jun Chen, University of Pittsburgh, Pittsburgh, USA
Thomas A. Kent, Baylor College of Medicine, Houston, USA
Paul A. Lapchak, Cedars-Sinai Medical Center, Los Angeles, USA
Miguel Perez-Pinzon, University of Miami, Miami, USA
Peter Vajkoczy, University of Berlin, Berlin, Germany
Guohua Xi, University of Michigan, Ann Arbor, USA
Editorial Board
Nabil Alkayed, Oregon Health Sciences University, Portland, USA
William M. Armstead, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
Jarek Aronowski, University of Texas Health Science Center, Houston, USA
Anish Bhardwaj, Tufts University Medical Center, Boston, USA
Klas Blomgren, Karolinska Institutet, Stockholm, Sweden
Cesar Borlongan, University of South Florida College of Medicine, Tampa, USA
Helen Bramlett, University of Miami, Miami, USA
Alastair Buchan, University of Oxford, Oxford, UK
Jieli Chen, Henry Ford Hospital, Detroit, USA
Michael Chopp, Henry Ford Health Science Center, Detroit, USA
Marilyn Cipolla, University of Vermont, Burlington, USA
Donald Degracia, Wayne State University School of Medicine, Detroit, USA
Rick Dijkhuizen, University Medical Center Utrecht, Utrecht, The Netherlands
Huanyu Dou, Texas Tech University Health Sciences Center, Texas, USA
Timothy Duong, University of Texas Health Science Center, San Antonio, USA
Nima Etminan, University of Düsseldorf, Düsseldorf, Germany
Susan Fagan, Medical College of Georgia, Augusta, USA
Mark Fisher, University of California, Irvine, USA
Myriam Fornage, University of Texas Health Science Center, Houston, USA
Jeffrey Gidday, Washington University, St. Louis, USA
Rona G. Giffard, Stanford University School of Medicine, Stanford, USA
Henrik Hagberg, Sahlgrenska University Hospital East, Göteborg, Sweden
Theo Hagg, University of Louisville, Louisville, USA
John Hallenbeck, NINDS, Bethesda, USA
David Hasan, University of Iowa Carver College of Medicine, Iowa City, USA
David Howells, University of Melbourne, Melbourne, Australia
Bingren Hu, University of Maryland School of Medicine, Baltimore, USA
Richard Keep, University of Michigan, Ann Arbor, USA
Sebastian Koch, University of Miami Miller School of Medicine, Miami, USA
Aij-Lei Kwan, Kaohsiung Medical University, Kaohsiung, Taiwan
Peter Lackner, Innsbruck Medical University, Innsbruck, Austria
Jin-Moo Lee, Washington University, St. Louis, USA
Klaus van Leyen, Harvard Medical School, Boston, USA
Weili Lin, University of North Carolina, Chapel Hill, USA
Eng Lo, Harvard University, Cambridge, USA
R. Loch Macdonald, St. Michael's Hospital, Toronto, Canada
Serge Marbacher, University of Bern, Bern, Switzerland
Bernhard Meyer, Ludwig-Maximilians-Universität Munich, Muenchen, Germany
Joan Montaner, Hospital Vall d'Hebron, Barcelona, Spain
MingMing Ning, Harvard University, Boston, USA
Shigeru Nishizawa, Hamamatsu University School of Medicine, KitaKyushu, Japan
Andre Obenaus, Loma Linda University, Loma Linda, USA
Hiroki Ohkuma, Hirosaki University, Hirosaki, Japan
Robert P. Ostrowski, Loma Linda University, School of Medicine, Loma Linda, USA
William Pearce, Loma Linda University, Loma Linda, USA
Keith R. Pennypacker, University of South Florida, Tampa, USA
Nikolaus Plesnila, Ludwig-Maximilians-University, Munich, Germany
William J. Powers, University of North Carolina School of Medicine, Chapel Hill, USA
Rajiv Ratan, Burke Rehabilitation, New York, USA
Veit Rohde, Universitätmedizin Göttingen, Goettingen, Germany
Sean I. Savitz, University of Texas Medical School, Houston, USA
Timothy Schallert, University of Texas, Austin, USA
Magdy Selim, Harvard Medical School, Boston, USA
Frank Sharp, University of California, Davis, USA
Norihito Shimamura, Hirosaki University School of Medicine, Hirosaki, Japan
Ihsan Solaroglu, Koç University School of Medicine, Istanbul, Turkey
Hua Su, University of California San Francisco School of Medicine, San Francisco, USA
Dandan Sun, University of Pittsburgh Medical Center, Pittsburgh, USA
Jiping Tang, Loma Linda University, Loma Linda, USA
Claudius Thome, Universität Heidelberg, Manheim, Germany
Hartmut Vatter, Goethe-Universität, Frankfurt, Germany
Raghu Vemuganti, University of Wisconsin, Madison, USA
Xiaoying Wang, Harvard Medical School, Charlestown, USA
Lawrence Wechsler, University of Pittsburgh Medical Center, Pittsburgh, USA
Ying Xia, University of Texas Medical School, Houston, USA
Xiao-Ming Xu, Indiana University School of Medicine, Indianapolis, USA
Zao C. Xu, Indiana University, Purdue, USA
Shaohua Yang, University of North Texas Health Science Center, Dallas, USA
Midori Yenari, University of California, San Francisco, USA
Shanping Yu, Emory University, Atlanta, USA
Heng Zhao, Stanford University, Stanford, USA
Mario Zuccarellow, University of Cincinnati, Cincinnati, USA
|
刊名字顺( Alphabetical List of Journals):
返回页首 